medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 10

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (10)

Perinatal outcomes of patients with intrahepatic cholestasis of pregnancy in a third level center in Mexico

Ibargüengoitia-Ochoa F, García-Romero CS, Sepúlveda-Rivera CM, Lira-Plascencia J, Gallardo-Gómez F

Language: Spanish
References: 38
Page: 760-769
PDF size: 212.71 Kb.


ABSTRACT

Objective: To describe the care, treatment, perinatal outcomes and complications associated with intrahepatic cholestasis of pregnancy.
Materials and Methods: A retrospective and observational case series study of pregnant patients with a diagnosis of intrahepatic cholestasis seen at the National Institute of Perinatology between January 2016 and December 2020. Obstetric characteristics, demographic, clinical, biochemical and treatment data, pregnancy termination and perinatal outcomes were evaluated.
Results: Sixty-seven cases of intrahepatic cholestasis were analyzed, yielding an incidence of 0.57%. The mean age of the patients was 29.0 ± 6.8 years, 30 of 67 were primigravidases, 12 had a history of intrahepatic cholestasis in the previous pregnancy and 7 had an abortion. The onset of the disease was in the third trimester in 41 of 67 patients. In biochemistry studies 32 of 67 had bile acid values between 10 and 39 µM/L; 12 of 67: 40-99 µM/L and 23 more than 100 (µM/L). Treatment with ursodeoxycholic acid was administered to 63 of 67 and rifampicin to 4 patients. The mean number of weeks of gestation was 35.6 ± 2.0 weeks with a mean weight of 2397 ± 572 g. Amniotic fluid with meconium was found in 10 neonates and growth restriction in 20 of 67; there were 2 recorded abortions.
Conclusions: This is the first study carried out in Mexico in which the incidence of the disease is described, and the determination of bile acids is used to establish the diagnosis. Perinatal outcomes coincide with those reported in the literature.


REFERENCES

  1. Guarino M, Cossiga V, Morisco F. The interpretation of liver function tests in pregnancy. Best Pract Res Clin Gastroenterol 2020; 44-45: 101667. https://doi.org/10.1016/j. bpg.2020.101667

  2. Mikolasevic I, Filipec K T, Jakopcic I, et al. Liver disease during pregnancy: a challenging clinical issue. Med Sci Monit 2018; 24: 4080-90. doi: 10.12659/MSM.907723

  3. Diken Z, Usta I M, Nassar A H. A clinical approach to intrahepatic cholestasis of pregnancy. Am J Perinatol 2014; 31: 1-8. doi:10.1055/s-0033-1333673

  4. Piechota J, Jelski W. Intrahepatic cholestasis of pregnancy: a review of the literature. J Clin Med 2020; 9: 1361-7. doi: https://doi.org/10.3390/jcm9051361

  5. Brouwers L, Koster MP, Page CGC, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015; 212: 100.e1-100.e7. doi:10.1016/j.ajog.2014.07.026

  6. Marschall H U. Management of intrahepatic cholestasis of pregnancy. Expert Rev Gastroenterol Hepatol 2015; 9: 1273-9. doi:10.1586/17474124.2015.1083857

  7. Ozkan S, Ceylan Y, Ozkan O V et al. Review of a challenging clinical issue: intrahepatic cholestasis of pregnancy. World J Gastroenterol 2015; 21: 7134-41. doi: 10.3748/wjg.V21. i23.7134

  8. Kawakita T, Parikh L I, Ramsey P S et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2015; 213: 570.e1-8. doi: org/10.1016/j.ajog.2015.06.021

  9. Reyes H, González M C, Ribalta J et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Inter Med 1978; 88: 487-93. doi:10.7326/0003-4819-88-4-487

  10. Deepak J, James A, Quaglia A et al. Liver disease in pregnancy. Lancet 2010; 375: 594-605. doi:10.1016/S0140- 6736(09)61495-1

  11. González B R, Mortara G A S, Martínez U A y col. Colestasis intra-hepática del embarazo: reporte de un caso y revisión de la bibliografía. Ginec Obstet Méx 2013; 81: 652-7. https://ginecologiayobstetricia.org.mx/articulo/ colestasis-intrahepatica-del-embarazo-reporte-de-uncaso- y-revision-de-la-bibliografia

  12. Gallardo G J M, Lemionet E D, Acevedo G S y col. Resultados perinatales adversos en colestasis intra-hepática del embarazo. Perinatol Reprod Hum 2018; 32: 131-7. DOI: https://www.sciencedirect.com/science/article/pii/ S0187533718301055

  13. Marschall H U, Wilkstorm S E, Ludvigsson J F et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 2013; 58: 1385-91. doi: https://doi.org/10.1002/ hep.26444

  14. Geenes V, Chappell L C, Seed P T et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based casecontrol study. Hepatogy 2014; 59: 1482-91. doi:10.1002/ hep.26617

  15. Ibrahim S H, Jonas M M, Taylor S A et al. Liver diseases in the perinatal period: interactions between mother and infant. Hepatology 2020; 71: 1474-85. doi:10.1002/hep.31109

  16. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014; 124: 120-33. doi: 10.1097/ AOG.0000000000000346

  17. Heikkinen J. Serum bile acids in the early diagnosis of intrahepatic cholestasis of pregnancy. Obstet Gynecol 1983; 61: 581-7. Serum Bile Acids in the Early Diagnosis of Intrahepatic Cholesterol. Obstetrics & Gynecology (lww.com)

  18. Prati D, Taioli E, Zanella A et al. Updated definitions of heatlhy ranges of serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10. doi:10.7326/0003-4819- 137-1-200207020-00006

  19. Katarey D, Westbrook R H. Pregnancy-specific liver diseases. Best Pract Res Clin Obstet Gynaecol 2020; 68: 12-22. doi: 10.1016/j.bpobgyn.2020.03.013

  20. Biccoca M J, Sperling J D, Cauhan S P. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018; 231: 180-7 doi: org/10.1016/j.ejogrb.2018.10.041

  21. Jin J, Pan S L, Huang L P et al. Risk factors for adverse fetal outcomes among women with early versus late-onset intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2015; 128: 236-40. doi:10.1016/j.ijgo.2014.09.013

  22. Ovadia C, Seed P, Sklavaunes A et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analysis. Lancet 2019; 393: 899-909. doi:org/10.1016/S0140-6736(18)31877-4

  23. Patel S, Pinheiro M, Felix J C. A case-control review of placentas from patients with intrahepatic cholestasis of pregnancy. Fetal Pediatr Pathol 2014; 33: 210-5.doi: 10.3109/15513815.2014.899413

  24. Herrera C A, Manuck T A, Stoddard G J et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med 2018; 31: 1913-20. DOI: https://doi.org/10.1080/14767058.2017.1332036.

  25. Ekiz A, Kaya B, Eftal A M et al. Alanine aminotransferase as a predictor of adverse perinatal outcome in women with intrahepatic cholestasis of pregnancy. Pak J Med Sci 2016; 32: 418-22. doi: org/10.12669/pjms.322.9057

  26. Li L, Chen Y H, Yang Y Y et al. Effect of intrahepatic cholestasis of pregnancy on neonatal birth weight: a meta-analysis. J Clin Res Pediatr Endocrinol 2018; 10: 38-43 doi: 10.4274/ jcrpe.4930

  27. Palma J, Reyes H, Ribalta J et al. Effects of ursodesoxicolic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992; 15: 1043-7. doi:10.1002/ hep.1840150612

  28. Bacq Y, Sentilhes L, Reyes H B et al. Efficacy of ursodesoxicolic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012: 143: 1492-501. doi:10.1053/j.gastro.2012.08.004

  29. Walker K F, Chappell L C, Hague W M et al. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev 2020; 7: CD 000493 doi: 10.1002/14651858.CD000493.pub3

  30. Geenes V, Chambers J, Khuruma R et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2015; 189: 59-63. doi: 10.1016/j.ejogrb.2015.03.020

  31. Wilkstrom S E, Marschall H U, Ludvigsson J F et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 2013; 120: 717-23. doi:10.1111/1471- 0528.12174.

  32. Arafa A, Dong J Y. Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and metaanalysis. Hypertens Pregnancy 2020; 39: 354-60. doi: 10.1080/10641955.2020.1758939

  33. Palmer K R, Xiaohua L, Mol B W. Management of intrahepatic cholestasis of pregnancy. Lancet 2019; 393: 853-4. doi: 10.1016/S0140-6736(18)32323-7

  34. Medically indicated late-preterm and early-term deliveries. ACOG Committee Opinion No. 764. American Collegue Obstetrics and Gynecology. Obstet Gynecol 2019; 133: e151-5. doi: 10.1097/AOG.0000000000003083

  35. Lee H L, Greenberg M, Metz ID, et al. Society of Maternal- Fetal Medicine Series # 53. Intrahepatic Cholestasis of Pregnancy. Am J Obstet Gynecol 2021; 224: B2-B9. doi: 10.1016/j.ajog.2020.11.002

  36. Wilkstrom S E A, Stephansson O, Thruresson M, et al. Intrahepatic cholestasis of pregnancy and cancer, immunemediated and cardiovascular diseases: a population-based cohort intrahepatic cholestasis study. J Hepatol 2015; 63: 456-61. doi: https://doi.org/10.1016/j.jhep.2015.03.010

  37. Floreani A, Garvasi M T. New insights on intrahepatic cholestasis of pregnancy. Clin Liv Dis 2016; 20: 177-89. doi: org/10.1016/j.cld.2015.08.010.

  38. Carballo-Núñez E y col. Resultados perinatales en pacientes con colestasis del embarazo. Ginecol Obstet Mex 2015; 83 (12): 776-84. https;//www.medigraphic.com/pdfs/ginobsmex/ gom-2015/gom1512f.pdf




2020     |     www.medigraphic.com